With that in mind, let's consider two stocks down 17% and 36%, respectively, this year that are worth investing in right now: Regeneron Pharmaceuticals ( REGN 0.40%) and Moderna ( MRNA -0.79%).

It is sad to see pets die of something easily preventable. It's even worse knowing that the owner was misinformed or misled ...

Find out how genome sequencing has emerged and what the future holds for one of biotech's most important tools.

Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...

Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...

The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...

Applications to speak at Disrupt 2025 on October 27–29 at Moscone West in San Francisco. Share your insights with 10,000+ ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

Plant breeding plays a vital role in ensuring global food security by increasing crop yields, improving nutritional quality ...

Vaccines have been a central focus for Trump's health leaders, but large-cap players aren't feeling the sting.

ORIC Pharmaceuticals is advancing ORIC-114 for 1st-line EGFR/HER2 exon 20 NSCLC, with comprehensive data expected in the 2nd ...

Orange County is home to some of the hottest medical device and biotechnology companies, producing a range of drugs and ...